- Home
- OPXS vs CLSD Comparison
OPXS vs CLSD Comparison
Compare OPXS & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPXS
- CLSD
- Stock Information
- Founded
- OPXS 1987
- CLSD 2011
- Country
- OPXS United States
- CLSD United States
- Employees
- OPXS N/A
- CLSD N/A
- Industry
- OPXS Electronic Components
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- OPXS Technology
- CLSD Health Care
- Exchange
- OPXS Nasdaq
- CLSD Nasdaq
- Market Cap
- OPXS 75.8M
- CLSD 68.4M
- IPO Year
- OPXS N/A
- CLSD 2016
- Fundamental
- Price
- OPXS $12.37
- CLSD $3.61
- Analyst Decision
- OPXS
- CLSD Hold
- Analyst Count
- OPXS 0
- CLSD 4
- Target Price
- OPXS N/A
- CLSD $65.00
- AVG Volume (30 Days)
- OPXS 46.1K
- CLSD 63.9K
- Earning Date
- OPXS 08-12-2025
- CLSD 11-11-2025
- Dividend Yield
- OPXS N/A
- CLSD N/A
- EPS Growth
- OPXS 23.32
- CLSD N/A
- EPS
- OPXS 0.75
- CLSD N/A
- Revenue
- OPXS $39,481,000.00
- CLSD $4,166,000.00
- Revenue This Year
- OPXS N/A
- CLSD $98.20
- Revenue Next Year
- OPXS N/A
- CLSD $213.77
- P/E Ratio
- OPXS $16.24
- CLSD N/A
- Revenue Growth
- OPXS 21.00
- CLSD N/A
- 52 Week Low
- OPXS $5.36
- CLSD $3.32
- 52 Week High
- OPXS $14.60
- CLSD $24.75
- Technical
- Relative Strength Index (RSI)
- OPXS 58.18
- CLSD 51.79
- Support Level
- OPXS $11.05
- CLSD $0.33
- Resistance Level
- OPXS $12.22
- CLSD $5.33
- Average True Range (ATR)
- OPXS 0.59
- CLSD 0.26
- MACD
- OPXS 0.15
- CLSD 0.23
- Stochastic Oscillator
- OPXS 94.15
- CLSD 65.47
About OPXS Optex Systems Holdings Inc.
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.